Krebs Biochemicals [KREBSBIO] vs Divi’s Laboratories [DIVISLAB] Detailed Stock Comparison

Krebs Biochemicals

NSE

Divi's Laboratories

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Krebs Biochemicals wins in 9 metrics, Divi's Laboratories wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric	Krebs Biochemicals	Divi's Laboratories	Better
P/E Ratio (TTM)	-6.03	69.41	Krebs Biochemicals
Price-to-Book Ratio	-1.11	10.69	Krebs Biochemicals
Debt-to-Equity Ratio	-1.45	0.03	Krebs Biochemicals
PEG Ratio	-0.17	107.11	Krebs Biochemicals
EV/EBITDA	-26.62	50.48	Krebs Biochemicals
Profit Margin (TTM)	-75.46%	23.89%	Divi's Laboratories
Operating Margin (TTM)	-67.04%	25.60%	Divi's Laboratories
EBITDA Margin (TTM)	N/A	25.60%	N/A
Return on Equity	18.42%	14.64%	Krebs Biochemicals
Return on Assets (TTM)	-15.94%	12.94%	Divi's Laboratories
Free Cash Flow (TTM)	$-114.54M	$2.15B	Divi's Laboratories
Dividend Yield	N/A	0.91%	N/A
1-Year Return	-0.93%	28.64%	Divi's Laboratories
Price-to-Sales Ratio (TTM)	4.56	16.59	Krebs Biochemicals
Enterprise Value	$3.76B	$1,547.23B	Divi's Laboratories
EV/Revenue Ratio	10.46	16.03	Krebs Biochemicals
Gross Profit Margin (TTM)	94.72%	60.33%	Krebs Biochemicals
Revenue per Share (TTM)	$17	$363	Divi's Laboratories
Earnings per Share (Diluted)	$-12.56	$86.88	Divi's Laboratories
Beta (Stock Volatility)	0.59	0.27	Divi's Laboratories

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Krebs Biochemicals vs Divi's Laboratories Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Krebs Biochemicals	-0.76%	0.84%	-4.11%	4.51%	-13.64%	-19.43%
Divi's Laboratories	0.46%	-6.99%	-12.06%	0.32%	-0.15%	-1.84%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Krebs Biochemicals	-0.93%	-31.03%	-10.30%	-20.34%	-20.34%	-20.34%
Divi's Laboratories	28.64%	61.27%	83.57%	388.63%	1,492.45%	8,232.40%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Krebs Biochemicals (KREBSBIO): View Full Stock Overview

Divi's Laboratories (DIVISLAB): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Krebs Biochemicals vs Divi's Laboratories

Metric	KREBSBIO	DIVISLAB
Market Information
Market Cap i	₹1.64B	₹1.60T
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	2,075	509,171
90 Day Avg. Volume i	3,795	351,540
Last Close	₹75.33	₹6,130.00
52 Week Range	₹66.12 - ₹129.07	₹4,615.55 - ₹7,071.50
% from 52W High	-41.64%	-13.31%
All-Time High	₹227.90 (Dec 27, 2021)	₹7,071.50 (Jul 08, 2025)
% from All-Time High	-66.95%	-13.31%
Growth Metrics
Quarterly Revenue Growth	-0.58%	0.14%
Quarterly Earnings Growth	-0.57%	0.27%
Financial Health
Profit Margin (TTM) i	-0.75%	0.24%
Operating Margin (TTM) i	-0.67%	0.26%
Return on Equity (TTM) i	0.18%	0.15%
Debt to Equity (MRQ) i	-1.45	0.03
Cash & Liquidity
Book Value per Share (MRQ)	₹-67.74	₹563.87
Cash per Share (MRQ)	₹0.07	₹132.86
Operating Cash Flow (TTM) i	₹-132,808,000	₹19.67B
Levered Free Cash Flow (TTM) i	₹-269,393,000	₹21.91B
Dividends
Last 12-Month Dividend Yield i	N/A	0.91%
Last 12-Month Dividend i	N/A	₹60.00

Valuation & Enterprise Metrics Analysis: Krebs Biochemicals vs Divi's Laboratories

Metric	KREBSBIO	DIVISLAB
Price Ratios
P/E Ratio (TTM) i	-6.03	69.41
Forward P/E i	N/A	107.11
PEG Ratio i	-0.17	107.11
Price to Sales (TTM) i	4.56	16.59
Price to Book (MRQ) i	-1.11	10.69
Market Capitalization
Market Capitalization i	₹1.64B	₹1.60T
Enterprise Value i	₹3.76B	₹1.55T
Enterprise Value Metrics
Enterprise to Revenue i	10.46	16.03
Enterprise to EBITDA i	-26.62	50.48
Risk & Other Metrics
Beta i	0.59	0.27
Book Value per Share (MRQ) i	₹-67.74	₹563.87

Financial Statements Comparison: Krebs Biochemicals vs Divi's Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	KREBSBIO	DIVISLAB
Revenue/Sales i	₹54.81M	₹24.10B
Cost of Goods Sold i	₹2.89M	₹9.56B
Gross Profit i	₹51.92M	₹14.54B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹-36.86M	₹6.17B
EBITDA i	₹-20.76M	₹8.48B
Pre-Tax Income i	₹-53.24M	₹7.33B
Income Tax i	₹0	₹1.88B
Net Income (Profit) i	₹-53.24M	₹5.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	KREBSBIO	DIVISLAB
Cash & Equivalents i	₹1.42M	₹4.15B
Total Current Assets i	₹102.59M	₹100.81B
Total Current Liabilities i	₹1.04B	₹14.52B
Long-Term Debt i	₹1.61B	₹20.00M
Total Shareholders Equity i	₹-1.46B	₹149.69B
Retained Earnings i	N/A	₹134.00B
Property, Plant & Equipment i	₹1.45B	₹3.19B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	KREBSBIO	DIVISLAB
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	KREBSBIO	DIVISLAB
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	2,075	509,171
Average Daily Volume (90 Day) i	3,795	351,540
Shares Outstanding i	21.56M	265.47M
Float Shares i	3.93M	120.74M
% Held by Insiders i	0.81%	0.52%
% Held by Institutions i	0.00%	0.29%

Dividend Analysis & Yield Comparison: Krebs Biochemicals vs Divi's Laboratories

Metric	KREBSBIO	DIVISLAB
Last 12-Month Dividend i	N/A	₹60.00
Last 12-Month Dividend Yield i	N/A	0.91%
3-Year Avg Annual Dividend i	N/A	₹50.00
3-Year Avg Dividend Yield i	N/A	0.70%
3-Year Total Dividends i	N/A	₹150.00
Ex-Dividend Date	N/A	Jul 25, 2025

Krebs Biochemicals [KREBSBIO] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison